Sector
PharmaceuticalsOpen
₹3,190.2Prev. Close
₹3,199.2Turnover(Lac.)
₹3,981.94Day's High
₹3,255Day's Low
₹3,17652 Week's High
₹3,515.752 Week's Low
₹1,921Book Value
₹115.06Face Value
₹10Mkt Cap (₹ Cr.)
54,438.63P/E
62.74EPS
51.09Divi. Yield
1.6817 May 2024
12:00 AM
AGM
Announcement Date: 17 May, 2024
13 May 2025
12:00 AM
Dividend
Dividend Amount: 42
Record Date: 30 May, 2025
17 Apr 2025
12:00 AM
Board Meeting
Agenda : Audited Result
Here are some of the stocks that may see significant price movement today: GIC Re, GSK Pharma, Godfrey Philips, etc.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 169.41 | 169.41 | 169.41 | 169.41 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,779.82 | 1,614.69 | 1,583.59 | 2,508.21 |
Net Worth | 1,949.23 | 1,784.1 | 1,753 | 2,677.62 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 3,217.5 | 2,920.47 | 3,224.68 | 2,871.68 |
yoy growth (%) | 10.17 | -9.43 | 12.29 | -1.07 |
Raw materials | -1,295.73 | -1,249.36 | -1,307.86 | -1,240.75 |
As % of sales | 40.27 | 42.77 | 40.55 | 43.2 |
Employee costs | -610.23 | -616.16 | -628.55 | -523.39 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 761.86 | 625.82 | 646.99 | 523.78 |
Depreciation | -68.18 | -78.6 | -82.67 | -37.98 |
Tax paid | -396.86 | -166.53 | -212.44 | -189.59 |
Working capital | 776.94 | 111.42 | 187.45 | -365.58 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 10.17 | -9.43 | 12.29 | -1.07 |
Op profit growth | 26.44 | -9.21 | 29.5 | 21.07 |
EBIT growth | 21.37 | -3.66 | 24.68 | 12.53 |
Net profit growth | 372.78 | 224.9 | -68.73 | 4.51 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 3,749.21 | 3,453.71 | 3,251.72 | 3,278.03 | 2,925.6 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 3,749.21 | 3,453.71 | 3,251.72 | 3,278.03 | 2,925.6 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 150.62 | 122.59 | 103.71 | 1,401.31 | 181.46 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.6 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,484 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.1 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,164 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
Subesh Williams
Chairperson
Renu S Karnad
Independent Director
Sunita Maheshwari
Independent Director
Manu Anand
Managing Director
Bhushan Akshikar
Whole Time Director & CFO
J. Chandy
Company Sec. & Compli. Officer
A A Nadkarni
Independent Director
Somasundaram Palamadairamaswamy
Independent Director
Anup Wadhawan
GSK House,
Dr Annie Besant Road Worli,
Maharashtra - 400030
Tel: 91-022-24959595
Website: http://www.gsk-india.com
Email: askus@gsk.com; ajay.a.nadkarni@gsk.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@kfintech.com
Summary
GlaxoSmithKline Pharmaceuticals Limited was erstwhile incorporated as Glindia Limited in November, 1924. The Company s name was changed to Glaxo (India) Limited from Glindia Limited in year 1987 and f...
Read More
Reports by Glaxosmithkline Pharmaceuticals Ltd
What is the Glaxosmithkline Pharmaceuticals Ltd share price today?
What is the Market Cap of Glaxosmithkline Pharmaceuticals Ltd?
What is the PE and PB ratio of Glaxosmithkline Pharmaceuticals Ltd?
What is the 52 Week High and Low of Glaxosmithkline Pharmaceuticals Ltd?
What is the CAGR of Glaxosmithkline Pharmaceuticals Ltd?
What is the shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
